• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $SPRY

    ARS Pharmaceuticals Inc.

    Subscribe to $SPRY
    $SPRY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    IPO Year: 2020

    Exchange: NASDAQ

    Recent Analyst Ratings for ARS Pharmaceuticals Inc.

    DatePrice TargetRatingAnalyst
    3/7/2025$30.00Sector Outperform
    Scotiabank
    2/10/2025$40.00Outperform
    Oppenheimer
    8/20/2024Overweight
    Cantor Fitzgerald
    8/13/2024$18.00 → $22.00Outperform → Strong Buy
    Raymond James
    8/12/2024$19.00 → $20.00Outperform
    Leerink Partners
    7/25/2024$18.00Outperform
    Raymond James
    3/5/2024$6.00 → $18.00Market Perform → Outperform
    Leerink Partners
    2/20/2024Mkt Perform → Outperform
    William Blair
    9/20/2023Outperform → Mkt Perform
    William Blair
    1/31/2023$10.00Outperform
    Wedbush
    See more ratings